Sleep Number Croissance future
Future contrôle des critères 3/6
Sleep Number devrait augmenter ses bénéfices et ses revenus de 79.8% et de 2.7% par an respectivement, tandis que le BPA devrait croître de croître de 81.6% par an.
Informations clés
79.8%
Taux de croissance des bénéfices
81.63%
Taux de croissance du BPA
| Specialty Retail croissance des bénéfices | 9.8% |
| Taux de croissance des recettes | 2.7% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 24 Apr 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour de l'analyse • Apr 21
SNBR: Marketing Reset And Product Overhaul Will Support Future Earnings Power
Analysts have sharply reduced Sleep Number's blended price target, with recent resets to $4 and $5 reflecting more cautious views on how current marketing efforts and new product launches are feeding through to sales and earnings. Analyst Commentary Recent Street research on Sleep Number has centered on how well the current marketing push and new product launches might translate into sustained earnings power, with price targets reset into the mid single digits as analysts reassess risk and execution.Mise à jour de l'analyse • Apr 06
SNBR: Marketing Reset And Product Overhaul Will Support Future Upside
Narrative Update on Sleep Number The analyst price target on Sleep Number has shifted lower into a $4 to $5 range, as analysts point to limited sales traction so far despite progress on marketing spend and new product launches. Analyst Commentary Recent research points to a mixed view on Sleep Number, with price targets now clustered in the low single digits and ratings held at Neutral.Mise à jour de l'analyse • Mar 21
SNBR: Marketing Reset And New Mattress Portfolio Will Support Future Upside
Sleep Number's updated fair value estimate has shifted from $11.00 to $4.50. This reflects analysts' recent cuts to price targets to around $4 to $5 as they weigh ongoing Neutral ratings against limited sales traction, despite some progress in marketing and new product launches.Mise à jour de l'analyse • Mar 07
SNBR: Improved Execution And Product Mix Will Support Rich Future P/E
Analysts have modestly increased their price targets on Sleep Number, with recent Street research indicating upward adjustments such as $4 and $7 moves as they factor in updated views on the company. Analyst Commentary Recent research updates point to a more constructive stance on Sleep Number, with price targets adjusted higher as analysts revisit their assumptions around the business and its execution risks.Mise à jour de l'analyse • Feb 20
SNBR: Higher Fair Value And Execution Progress Will Support Rich P/E
Narrative Update on Sleep Number The updated analyst price target for Sleep Number moves from $9.00 to $11.00. This reflects analysts’ refreshed views on fair value, discount rate, revenue growth, profit margin, and future P/E following recent target increases from multiple firms.Mise à jour de l'analyse • Feb 05
SNBR: Margin Optimism And High Future P/E Will Likely Disappoint
Analysts have raised their price targets on Sleep Number by about $7, citing updated expectations for revenue growth, profit margins and future P/E assumptions that refine their overall outlook on the shares. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the revised price target, which is $7 higher, reflects more confidence in Sleep Number’s ability to translate its current revenue outlook into steadier earnings over time.
Nouvelle analyse • Feb 02
Premium Pricing And Flat Revenue Will Pressure Margins And Undermine Turnaround Hopes
Catalysts About Sleep Number Sleep Number designs, manufactures and sells premium adjustable mattresses and sleep systems that focus on comfort, firmness control and temperature management. What are the underlying business or industry changes driving this perspective?Mise à jour de l'analyse • Jan 22
SNBR: Elevated Future P/E Will Likely Fail To Support Price
Analysts have raised their fair value estimate for Sleep Number from $5.50 to $9.00, reflecting revisions to revenue growth and profit margin assumptions, as well as a significantly higher future P/E multiple that supports the updated price targets cited in recent research. Analyst Commentary Recent research commentary around Sleep Number centers on how changes to revenue and margin assumptions flow through to the updated fair value and price targets, including the move from a prior US$5.50 view to US$9.00.Article d'analyse • Jan 17
Sleep Number Corporation's (NASDAQ:SNBR) Shares Climb 38% But Its Business Is Yet to Catch Up
Despite an already strong run, Sleep Number Corporation ( NASDAQ:SNBR ) shares have been powering on, with a gain of...Mise à jour de l'analyse • Jan 07
SNBR: Future Earnings Guidance And Margins Will Likely Fail To Support Price
Analysts have modestly adjusted their price targets on Sleep Number, citing refined assumptions around long term revenue growth of 77.30%, a profit margin of 4.86% and a future P/E of 2.62x as key drivers of their updated valuation work. What's in the News Amy O’Keefe has been appointed as Sleep Number’s next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder staying through December 12, 2025 to support the transition (company announcement).Article d'analyse • Jan 07
Is There An Opportunity With Sleep Number Corporation's (NASDAQ:SNBR) 48% Undervaluation?
Key Insights The projected fair value for Sleep Number is US$14.44 based on 2 Stage Free Cash Flow to Equity Sleep...Mise à jour de l'analyse • Dec 23
SNBR: Future Margin Gains Will Likely Prove Insufficient For Current Price
Narrative Update on Sleep Number Analysts have modestly lowered their price target on Sleep Number to approximately $5.50 per share, reflecting slightly more cautious expectations around the company’s profitability and valuation multiple, while growth assumptions remain largely unchanged. What's in the News Appointed Amy O’Keefe as next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder supporting a brief transition period through December 12, 2025 (company filing) Highlighted O’Keefe’s more than 30 years of experience driving operational, strategic, and financial transformations across consumer products, technology, and wellness companies, including senior roles at Avaya, Weight Watchers, and Drive DeVilbiss Healthcare (company filing) Reaffirmed 2025 earnings guidance, projecting approximately $1.4 billion in net sales and about 60% gross margin for the full year (company guidance) Revised 2025 outlook earlier in the year to call for roughly $1.4 billion in net sales, indicating stable but not accelerating expectations for revenue growth (company guidance) Reported no share repurchases between June 29 and September 27, 2025, while confirming cumulative buybacks of about 50.1 million shares for $1.77 billion under a long running repurchase program launched in 2006 (company disclosure) Valuation Changes Fair Value Estimate: unchanged at approximately $5.50 per share, indicating no material shift in the intrinsic value assessment.Seeking Alpha • Dec 11
Sleep Number Navigates A Challenging Consumer Market When Time Is Critical
Summary Sleep Number Corporation (SNBR) receives a Sell rating with a $5.64 price target, reflecting deep financial and operational challenges. SNBR is aggressively restructuring — cutting costs, reducing assets, and revamping management — to restore profitability amid a weak consumer environment. Elevated leverage (6.80x net debt/aEBITDA) and tightened credit covenants heighten risk, with profitability not expected until FY27. Despite a discounted 0.12x price/sales multiple, SNBR may be a value trap given debt risks and uncertain turnaround prospects. Read the full article on Seeking AlphaMise à jour de l'analyse • Dec 09
SNBR: Modest Margin Improvement Will Likely Fail To Support Current Share Price
Analysts have modestly lowered their price target on Sleep Number to reflect a slightly reduced future earnings multiple of about 2.62 times, while still acknowledging stable fair value at 5.50 dollars, unchanged discount rates, and a marginally improved profit margin outlook. What's in the News Sleep Number appointed Amy O’Keefe as its next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder supporting the transition through December 12, 2025 (Key Developments) O’Keefe brings more than 30 years of experience in financial and operational transformations across consumer products, technology, and wellness companies, including senior finance roles at Avaya, Weight Watchers, Drive DeVilbiss Healthcare, Savant Systems, and D&M Holdings (Key Developments) The company reaffirmed its full year 2025 guidance, targeting approximately 1.4 billion dollars in net sales and a gross margin of about 60% (Key Developments) Earlier in 2025, Sleep Number revised guidance to project full year net sales of approximately 1.4 billion dollars, signaling a consistent outlook for top line performance (Key Developments) Under its long running share repurchase program launched in 2006, the company reported no share buybacks between June 29 and September 27, 2025, while confirming cumulative repurchases of 50,132,467 shares for 1.77 billion dollars (Key Developments) Valuation Changes Fair Value: Unchanged at 5.50 dollars per share, indicating no revision to the intrinsic value estimate.Mise à jour de l'analyse • Nov 25
SNBR: Margin Gains Will Strengthen Bullish Outlook Despite Slower Top Line
Analysts have lowered their price target for Sleep Number from $6.95 to $2.69, citing reduced revenue growth expectations. However, they also note improved profit margin projections.Mise à jour de l'analyse • Nov 07
SNBR: Improved Margins And Revenue Will Drive Bullish Sentiment Ahead
Analysts have lowered their price target for Sleep Number from $7.50 to $5.50, reflecting cautious optimism over improved revenue growth and slightly better profit margins, even as valuation multiples decline. What's in the News Sleep Number Corporation revised its earnings guidance for 2025.Article d'analyse • Jul 29
Optimistic Investors Push Sleep Number Corporation (NASDAQ:SNBR) Shares Up 34% But Growth Is Lacking
Sleep Number Corporation ( NASDAQ:SNBR ) shareholders would be excited to see that the share price has had a great...Article d'analyse • May 09
Sleep Number Corporation's (NASDAQ:SNBR) 62% Price Boost Is Out Of Tune With Revenues
Sleep Number Corporation ( NASDAQ:SNBR ) shareholders are no doubt pleased to see that the share price has bounced 62...Article d'analyse • May 03
Analysts Have Been Trimming Their Sleep Number Corporation (NASDAQ:SNBR) Price Target After Its Latest Report
As you might know, Sleep Number Corporation ( NASDAQ:SNBR ) recently reported its quarterly numbers. It was a pretty...
Nouvelle analyse • May 02
Cost Cuts And Product Differentiation Will Improve Operations
Product innovation in Climate Series beds and ARU expansion highlights potential revenue growth through consumer-focused differentiation.Seeking Alpha • Mar 12
Sleep Number Crashes As Risks Are Mounting, But Not Everything Is Lost
Summary SNBR stock crashed almost 42% on its earnings release and closed at a 52-week low, reflecting a myriad of risks investors are worried about. As consumer confidence slumps, the expected rebound in the U.S. mattress industry may not happen in 2025 yet, while tariffs are a key risk to SNBR’s margins and liquidity. The recently announced CEO change and open misalignment with major shareholder Stadium Capital on Board changes are creating additional uncertainty. On the flip side, risks are now largely priced in, meaning that any improvement in consumer sentiment could become a material upside catalyst. While I maintain my HOLD rating, this is a high-risk / high-reward bet for risk-tolerant traders, not suited for value or quality investors. Read the full article on Seeking AlphaArticle d'analyse • Dec 04
Sleep Number Corporation's (NASDAQ:SNBR) 29% Price Boost Is Out Of Tune With Revenues
Sleep Number Corporation ( NASDAQ:SNBR ) shares have had a really impressive month, gaining 29% after a shaky period...Seeking Alpha • Nov 26
Sleep Number: Navigating Market Cycles While Building Operational Excellence
Summary Sleep Number demonstrates operational resilience with improving margins (60.8%) and positive free cash flow ($34M) despite revenue headwinds, showing strong execution in a challenging market environment. Technology leadership position and smart bed capabilities create significant competitive advantage, though higher SG&A costs (55%) reflect challenges to educate consumers about air mattress. Trading at historical low valuation (0.7x EV/Sales) with record discount to Tempur Sealy. Near-term headwinds include CEO transition after 12-year tenure, severe housing market slowdown, and increased competition from Tempur Sealy's planned Mattress Firm acquisition. Read the full article on Seeking AlphaArticle d'analyse • Nov 02
Sleep Number Corporation (NASDAQ:SNBR) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Shareholders might have noticed that Sleep Number Corporation ( NASDAQ:SNBR ) filed its quarterly result this time last...Article d'analyse • Oct 05
Revenues Not Telling The Story For Sleep Number Corporation (NASDAQ:SNBR) After Shares Rise 29%
Sleep Number Corporation ( NASDAQ:SNBR ) shares have continued their recent momentum with a 29% gain in the last month...Seeking Alpha • Sep 17
Sleep Number- Coping Well In A Difficult Environment
Summary Industry sales are expected to wobble for yet another year, but the improvements that SNBR has facilitated on the cost base could see it generate marginal EBITDA growth this year. Looking ahead, even if the topline growth ends up being anemic, EBITDA growth in FY25 and FY26 are poised to come in at double-digit growth levels. The stock is still priced at a discount on a forward EV/EBITDA basis, although that discount has come down from 30% in March to 12.5% currently. FCF in H1-24 was $21m better than what it was in H1-23, and in H2-24 alone, SNBR looks set to generate $40-$60m worth of FCF that could help bring the leverage ratio down to 3.75x. SNBR still looks oversold vs other small-cap discretionary stocks and bullish momentum appears to have kickstarted. Read the full article on Seeking AlphaArticle d'analyse • Aug 18
Optimistic Investors Push Sleep Number Corporation (NASDAQ:SNBR) Shares Up 28% But Growth Is Lacking
Those holding Sleep Number Corporation ( NASDAQ:SNBR ) shares would be relieved that the share price has rebounded 28...Article d'analyse • Jun 19
Some Sleep Number Corporation (NASDAQ:SNBR) Shareholders Look For Exit As Shares Take 28% Pounding
Sleep Number Corporation ( NASDAQ:SNBR ) shares have had a horrible month, losing 28% after a relatively good period...Seeking Alpha • Mar 29
Sleep Number: Re-Rating Following Decline In Performance
Summary Sleep Number’s revenue has grown well (CAGR: +7%), owing to successful product innovation and brand development, contributing to market share growth. The company has executed well, with significant potential as consumer awareness improves and it optimizes its software offering. This said, mistakes and weaknesses have led to a capitulation in performance, with the company’s long-term trajectory fundamentally weakened. We believe margins will normalize below its historical average, while economic conditions and industry fundamentals will mean medium-term growth is lower than historical levels. We believe Sleep Number is overvalued, with its current valuation suggesting better than forecast margin improvement, which we struggle to see materializing. Read the full article on Seeking AlphaArticle d'analyse • Dec 11
Is It Too Late To Consider Buying Sleep Number Corporation (NASDAQ:SNBR)?
Sleep Number Corporation ( NASDAQ:SNBR ), might not be a large cap stock, but it received a lot of attention from a...Article d'analyse • Nov 09
Bearish: Analysts Just Cut Their Sleep Number Corporation (NASDAQ:SNBR) Revenue and EPS estimates
Market forces rained on the parade of Sleep Number Corporation ( NASDAQ:SNBR ) shareholders today, when the analysts...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 1,541 | 28 | 52 | 82 | 2 |
| 12/31/2027 | 1,461 | 6 | 48 | 67 | 4 |
| 12/31/2026 | 1,365 | -16 | 4 | 30 | 4 |
| 1/3/2026 | 1,411 | -132 | -21 | -3 | N/A |
| 9/27/2025 | 1,441 | -78 | -50 | -29 | N/A |
| 6/28/2025 | 1,525 | -41 | -16 | 5 | N/A |
| 3/29/2025 | 1,605 | -21 | -28 | -9 | N/A |
| 12/28/2024 | 1,682 | -20 | 4 | 27 | N/A |
| 9/28/2024 | 1,735 | -41 | -16 | 10 | N/A |
| 6/29/2024 | 1,781 | -40 | -45 | -4 | N/A |
| 3/30/2024 | 1,831 | -34 | -45 | 6 | N/A |
| 12/30/2023 | 1,887 | -15 | -66 | -9 | N/A |
| 9/30/2023 | 1,955 | 4 | -77 | -12 | N/A |
| 7/1/2023 | 2,023 | 12 | -37 | 26 | N/A |
| 4/1/2023 | 2,114 | 46 | -35 | 30 | N/A |
| 12/31/2022 | 2,114 | 37 | -33 | 36 | N/A |
| 10/1/2022 | 2,109 | 53 | 17 | 87 | N/A |
| 7/2/2022 | 2,209 | 102 | 96 | 167 | N/A |
| 4/2/2022 | 2,144 | 89 | 138 | 213 | N/A |
| 1/1/2022 | 2,185 | 154 | 233 | 300 | N/A |
| 10/2/2021 | 2,261 | 204 | 226 | 285 | N/A |
| 7/3/2021 | 2,152 | 202 | 306 | 354 | N/A |
| 4/3/2021 | 1,952 | 167 | 266 | 306 | N/A |
| 1/2/2021 | 1,857 | 139 | 241 | 280 | N/A |
| 9/26/2020 | 1,730 | 102 | 245 | 287 | N/A |
| 6/27/2020 | 1,673 | 79 | 158 | 206 | N/A |
| 3/28/2020 | 1,744 | 96 | 156 | 206 | N/A |
| 12/28/2019 | 1,698 | 82 | N/A | 189 | N/A |
| 9/28/2019 | 1,669 | 85 | N/A | 187 | N/A |
| 6/29/2019 | 1,609 | 75 | N/A | 173 | N/A |
| 3/30/2019 | 1,569 | 74 | N/A | 150 | N/A |
| 12/29/2018 | 1,532 | 70 | N/A | 132 | N/A |
| 9/29/2018 | 1,483 | 58 | N/A | 131 | N/A |
| 6/30/2018 | 1,471 | 66 | N/A | 113 | N/A |
| 3/31/2018 | 1,439 | 61 | N/A | 135 | N/A |
| 12/30/2017 | 1,444 | 65 | N/A | 173 | N/A |
| 9/30/2017 | 1,395 | 61 | N/A | 182 | N/A |
| 7/1/2017 | 1,360 | 61 | N/A | 193 | N/A |
| 4/1/2017 | 1,352 | 63 | N/A | 175 | N/A |
| 12/31/2016 | 1,311 | 51 | N/A | 152 | N/A |
| 10/1/2016 | 1,213 | 19 | N/A | 122 | N/A |
| 7/2/2016 | 1,218 | 25 | N/A | 110 | N/A |
| 4/2/2016 | 1,217 | 35 | N/A | 123 | N/A |
| 1/2/2016 | 1,214 | 51 | N/A | 108 | N/A |
| 10/3/2015 | 1,321 | 91 | N/A | 140 | N/A |
| 7/4/2015 | 1,271 | 82 | N/A | 140 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: SNBR devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 3.5% ).
Bénéfices vs marché: SNBR devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.
Croissance élevée des bénéfices: SNBR devrait devenir rentable dans les 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de SNBR ( 2.7% par an) devrait croître plus lentement que le marché de US ( 11.6% par an).
Croissance élevée des revenus: Le chiffre d'affaires de SNBR ( 2.7% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de SNBR devrait être élevé dans 3 ans
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/11 21:11 |
| Cours de l'action en fin de journée | 2026/05/08 00:00 |
| Les revenus | 2026/01/03 |
| Revenus annuels | 2026/01/03 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Sleep Number Corporation est couverte par 15 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| null null | Argus Research Company |
| Jessica Schoen Mace | Barclays |
| Curtis Nagle | BofA Global Research |